Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Lannett Company Inc (LCI)

Lannett Company Inc (LCI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Lannett Company Inc 1150 NORTHBROOK DRIVE SUITE 155 TREVOSE PA 19053 USA

www.lannett.com P: 215-333-9000

Description:

Lannett Company manufactures and distributes high quality affordable generic medications that are the therapeutic equivalent of the brand-name pharmaceuticals. Their portfolio consists of numerous products across a wide range of therapeutic areas. Lannett believes that their ability to select viable products for development, efficiently develop such products, including obtaining any applicable regulatory approvals, vertically integrate themselves into certain specialty markets and achieve economies in production are all critical for their success in the generic pharmaceutical industry in which they operate. Lannett Company, Inc., continues to dedicate significant capital toward developing new products as they believe their success is linked to their ability to continually introduce new generic products into the marketplace.

Key Statistics

Overview:

Market Capitalization, $K 7,381
Enterprise Value, $K 534,481
Shares Outstanding, K 10,767
Annual Sales, $ 340,580 K
Annual Net Income, $ -231,620 K
Last Quarter Sales, $ 80,890 K
Last Quarter Net Income, $ -36,310 K
60-Month Beta 0.95
% of Insider Shareholders 13.12%
% of Institutional Shareholders 40.28%
Float, K 9,354
% Float 86.88%
Short Volume Ratio 0.45

Growth:

1-Year Return -75.99%
3-Year Return -98.12%
5-Year Return -98.94%
5-Year Revenue Growth -46.22%
5-Year Earnings Growth -152.80%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -1.36 on 02/01/23
Latest Earnings Date 05/03/23
Earnings Per Share ttm -6.44
EPS Growth vs. Prev Qtr 19.05%
EPS Growth vs. Prev Year 12.82%
Annual Dividend Rate, $ 0.00
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%
Most Recent Split 1-4 on 02/07/23

LCI Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % 0.00%
Return-on-Assets % -13.39%
Profit Margin % -68.01%
Debt/Equity -2.00
Price/Sales 0.02
Price/Cash Flow N/A
Price/Book N/A
Book Value/Share -29.77
Interest Coverage -3.03
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar